Medtronic
Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System
“SNM therapy is already proven to be safe and effective, but we expect the ELITE study to definitively reinforce established SNM evidence in patients implanted with the new InterStim Micro system,” said Victor Nitti, M.D., the Shlomo Raz Chair in urology, professor of urology and obstetrics and gynecology, and chief and fellowship director of Female Pelvic Medicine and Reconstructive Surgery at the David Geffen School of Medicine at UCLA.
InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads Receive FDA Approval
InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads make Medtronic the only company to offer patients and physicians a choice in SNM systems to match their preferences, lifestyle and treatment goals.
LINQ II Insertable Cardiac Monitor Receives FDA Clearance and CE Mark
LINQ II™ insertable cardiac monitor is a small (one-third the size of a AAA battery), wireless ICM for patients with abnormal heart rhythms who experience infrequent symptoms including dizziness, palpitations, syncope (fainting) and chest pain, thereby requiring long-term monitoring or ongoing management.
Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.
The MiniMed™ Mio™ Advance infusion set s inserted in only four steps. Individuals simply peel, pinch, place, and press to insert the infusion set.
Percept PC Deep Brain Stimulation System with BrainSense Technology Receives FDA Approval
BrainSense™ technology makes Percept the first and only DBS neurostimulation system with the ability to chronically capture and record brain signals while delivering therapy to patients with neurologic disorders associated with Parkinson’s disease, essential tremor, dystonia, epilepsy or obsessive-compulsive disorder.
Medtronic Evolut TAVI System Receives Expanded Indication in Europe to Treat Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
The Evolut TAVI System, with its excellent hemodynamics, allows for improved heart function that helps many patients resume their pre-aortic stenosis activity.
ABRE Clinical Study Meets Primary Safety and Effectiveness Endpoints
The ABRE Study is a prospective, interventional, single-arm, multi-center, worldwide study, which included 200 subjects with symptomatic iliofemoral venous outflow obstruction from 24 sites throughout the U.S. and Europe.
Medtronic Micra™ AV Receives CE Mark
Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical signals between the chambers of the heart (the atria and the ventricle) are impaired.
MiniMed 780G Advanced Hybrid Closed Loop System Designed to Further Simplify Type 1 Diabetes Management Receives CE Mark
The system enables the personalization of glucose goals with an adjustable target setting as low as 100 mg/dL (5.5 mmol/L) — lower than any other advanced hybrid closed-loop system — and is designed to help stabilize blood sugar levels and further improve glucose control.
Medtronic Resolute Onyx DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe
Resolute Onyx DES is available for use in the United States, as well as in Europe and other countries that recognize the CE Mark. Resolute Onyx DES is not currently indicated for HBR patients with one-month DAPT in the United States. Data have been submitted to the FDA with the intent of obtaining a one-month DAPT US Indication for Resolute Onyx DES.
